A special MRI scan to guide radiation for glioblastoma that has come back
Official title: Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is testing whether an experimental MRI scan can help doctors find hidden brain cancer and aim radiation at it.
Read our full plain-language summary
What the trial team says
The purpose of this research is to find hidden cancer with an experimental magnetic resonance imaging (MRI) scan called spectroscopic magnetic resonance imaging (sMRI). That spectroscopic MRI scan will be used to increase the area of the brain receiving radiation and then the dose of radiation in attempt to kill more of the cancer. Proton radiotherapy and bevacizumab (Avastin) are used to minimize the possible side effects of this approach.
Key facts
- Registry number
- NCT05284643
- Stage of testing
- Not applicable
- Conditions studied
- Recurrent Glioblastoma
Where it is running
This trial lists 1 site.
-
Florida
- University of Miami (Miami)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.